|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$58,966.20 |
2.89% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$50,844.03 |
2.50% |
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$45,930.60 |
2.25% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$45,674.86 |
2.24% |
| Waters Corporation |
WAT |
941848103 |
120 |
$45,357.60 |
2.23% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$45,097.41 |
2.21% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$44,849.35 |
2.20% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$43,668.46 |
2.14% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$43,426.68 |
2.13% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$43,323.95 |
2.13% |
| Steris Plc |
STE |
G8473T100 |
169 |
$43,434.69 |
2.13% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$43,104.16 |
2.12% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$43,057.76 |
2.11% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$42,857.66 |
2.10% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$42,535.68 |
2.09% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$42,612.03 |
2.09% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$42,199.84 |
2.07% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$42,106.48 |
2.07% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$42,037.37 |
2.06% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$41,658.54 |
2.05% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$41,597.05 |
2.04% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$41,159.12 |
2.02% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$40,869.72 |
2.01% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$40,744.04 |
2.00% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$40,596.22 |
1.99% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$40,580.28 |
1.99% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$40,393.28 |
1.98% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$40,245.04 |
1.98% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$40,191.69 |
1.97% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$40,021.61 |
1.96% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$39,886.32 |
1.96% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$39,694.06 |
1.95% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$39,254.17 |
1.93% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$39,139.03 |
1.92% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$38,199.38 |
1.88% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$37,961.24 |
1.86% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$37,803.92 |
1.86% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$37,295.15 |
1.83% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$37,317.44 |
1.83% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$37,037.72 |
1.82% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$36,866.01 |
1.81% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$36,862.82 |
1.81% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$36,221.42 |
1.78% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$36,071.74 |
1.77% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$35,972.37 |
1.77% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$35,795.88 |
1.76% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$35,075.87 |
1.72% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$34,689.24 |
1.70% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$32,288.09 |
1.59% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$31,611.45 |
1.55% |
| US Dollar |
$USD |
|
2,092 |
$2,091.88 |
0.10% |
| Japanese Yen |
$JPY |
|
102,506 |
$660.31 |
0.03% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.14 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|